Communication Bridge Speech Therapy Research Study

Frontotemporal Dementia Clinical Trial

Official title:

Communication Bridge Speech Therapy Research Study: Using Internet-Based Speech Therapy to Improve Quality of Life and Access to Care

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02439853
• Other study ID #: STU00073634
• Status: Completed
• Phase: N/A
• Start date: March 2013
• Est. completion date: January 2020

Study information

• Verified date: November 2022
• Source: Northwestern University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a study on Internet-based video-practice speech and language therapy for persons with primary progressive aphasia (PPA), behavioral-variant frontotemporal dementia (bvFTD), or related conditions.

Description:

The purpose of this study is:

1. To evaluate the effectiveness of speech and language therapy on a person's ability to communicate immediately after treatment, 6-months after treatment, and 12-months after treatment.

2. To identify the most effective speech and language therapy strategies for persons with these conditions.

3. To determine the feasibility of Internet-based video-practice of speech and language therapy for persons with these conditions.

The study will involve 12 to 15 session over the course of 12 months. Some of these sessions will be in-person at the Northwestern Cognitive Neurology and Alzheimer's Disease Center (Chicago, IL), while others will take place over the Internet, using an online study portal.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 57
• Est. completion date: January 2020
• Est. primary completion date: December 2019
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• Diagnosis of dementia with language as a primary symptom (i.e. aphasia)

• An informant who knows the participant well and can answer questions the participant's communication ability

• Adequate hearing to follow conversation (correction permitted)

• Adequate vision (correction permitted)

Related Conditions & MeSH terms

• Aphasia
• Aphasia, Primary Progressive
• Communication Disorders
• Dementia
• Frontotemporal Dementia
• Pick Disease of the Brain
• Primary Progressive Aphasia

Intervention

Behavioral:
• Monthly Check-in Session
Subjects in the Check-In group will have an online session with a speech-language pathologist 3-, 4-, and 5-months from the subject's enrollment date.

Locations

Country	Name	City	State
United States	Northwestern University	Chicago	Illinois

Sponsors (5)

Lead Sponsor	Collaborator
Northwestern University	Alzheimer's Association, Illinois Department of Public Health, National Institutes of Health (NIH), The Association for Frontotemporal Degeneration

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Assessment of Functional Communication Abilities	Functional Communication Abilities will be assessed through questionnaires about the participant's language and communication, neuropsychological testing, and speech and language therapy evaluations.	Change from baseline assessment at 2-months, 6-months and 12-months post-treatment